Blood tests measure the level of PSA protein, produced by the prostate gland, and may help detect early signs of prostate ...
Novartis’ radioligand therapy Pluvicto (lutetium Lu 177 vipivotide tetraxetan) has been approved by the US Food and Drug ...
The PIK3CA wild-type cohort of the VIKTORIA-1 Phase 3 trial is on track to report topline data in Q2 2025VIKTORIA-2 Phase 3 ...
The FDA expanded the approval of Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to include patients with PSMA-positive mCRPC who have been treated with ARPI therapy and are considered appropriate to ...
Good afternoon, ladies and gentlemen, and welcome to the Celcuity fourth quarter and full year 2024 financial results webcast conference call. (Operator Instructions) I would now like to turn the ...
Q4 2024 Earnings Call Transcript March 31, 2025 Celcuity Inc. misses on earnings expectations. Reported EPS is $-0.85 EPS, ...
News Medical on MSN10h
World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in menThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...
Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...
BREAKING: Following Dobbs v. Jackson, the United States saw a 10 percent increase in interest for new male contraceptives, and nearly half of surveyed men were interested in starting one within the ...
Communication between health-care professionals and individuals with cancer regarding the effects of treatment on sexual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback